A detailed history of Financially Speaking Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Financially Speaking Inc holds 891 shares of JNJ stock, worth $139,111. This represents 0.09% of its overall portfolio holdings.

Number of Shares
891
Holding current value
$139,111
% of portfolio
0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$143.34 - $165.86 $127,715 - $147,781
891 New
891 $129 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $408B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Financially Speaking Inc Portfolio

Follow Financially Speaking Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financially Speaking Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financially Speaking Inc with notifications on news.